Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease

Joanna Schwenkgrub(Centre National de la Recherche Scientifique), Andrzej Członkowski(Medical University of Warsaw), Ilona Joniec‐Maciejak(Medical University of Warsaw), Agnieszka Ciesielska(Gladstone Institutes), Anna Członkowska(Institute of Psychiatry and Neurology), Adriana Wawer(Medical University of Warsaw), Krzysztof S. Bankiewicz(University of California, San Francisco), Anna Sznejder-Pachołek(Medical University of Warsaw)

Pharmacological Reports

January 1, 2013

10.1016/s1734-1140(13)70962-9

Cited by 34

Related Papers

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

|The Lancet|2012|1.2k

Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial

|The Lancet Neurology|2018|178

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

|Neurology|2021|155

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease

|Neurology|2005|122

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

|The Lancet Neurology|2023|95